TABLE 2

Observed distributions of P-glycoprotein substrate verapamil to brain in control, pentylenetetrazole, phenytoin, and spontaneous model of epilepsy mice

Mice received constant intravenous infusion of verapamil to the jugular vein at a rate of 500 nmol/h per kg following 1-minute rapid infusion (500 nmol/min per kg). The plasma and brain concentrations were measured at 45 minutes, and the brain-to-plasma concentration ratio (Kp brain) values were calculated by dividing the brain concentration by the plasma concentration. Each value represents the mean ± S.E.M. (n = 3–4).

Plasma ConcentrationBrain ConcentrationKp brain
nMpmol/g brainml/g brain
Control101 ± 956.7 ± 8.30.563 ± 0.074
PTZ93.4 ± 3.436.6 ± 2.20.394 ± 0.034
EL156 ± 766.3 ± 9.70.432 ± 0.084
PHT83.0 ± 6.719.2 ± 1.20.234 ± 0.016**
  • ** P < 0.01: significantly different from Kp brain value in control mice (Dunnett’s test).